126 related articles for article (PubMed ID: 3122820)
1. Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women.
Bazin B; Thevenot R; Bursaux C; Paris J
Br J Obstet Gynaecol; 1987 Dec; 94(12):1199-204. PubMed ID: 3122820
[TBL] [Abstract][Full Text] [Related]
2. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
[TBL] [Abstract][Full Text] [Related]
3. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationship between Uniplant insertion and changes in cervical mucus.
Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
[TBL] [Abstract][Full Text] [Related]
5. [Antigonadotropic effects of a 19-nor-progesterone derivative: the example of nomegestrol acetate].
Jamin C; Batallan A; Madelenat P
Gynecol Obstet Fertil; 2003 Jan; 31(1):70-81. PubMed ID: 12659788
[TBL] [Abstract][Full Text] [Related]
6. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
7. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
8. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive potential of a mifepristone-nomegestrol acetate sequential regimen in women.
Croxatto HB; Salvatierra AM; Fuentealba B; Massai R
Hum Reprod; 1998 Dec; 13(12):3297-302. PubMed ID: 9886502
[TBL] [Abstract][Full Text] [Related]
12. Effects of 180 micrograms and 250 micrograms norgestimate on pituitary-ovarian function and cervical mucus.
Eyong E; Buchi K; Elstein M
Fertil Steril; 1988 Nov; 50(5):756-60. PubMed ID: 3141219
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant).
Barnhart K; Devoto L; Pommer R; Sir-Pettermann T; Robinovic J; Coutinho E
Fertil Steril; 1997 Feb; 67(2):250-5. PubMed ID: 9022598
[TBL] [Abstract][Full Text] [Related]
14. The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound.
Skouby SO
Contraception; 1976 Nov; 14(5):529-39. PubMed ID: 989747
[No Abstract] [Full Text] [Related]
15. Pituitary and ovarian hormone secretion and ovulation in gilts injected with gonadotropins during and after oral administration of progesterone agonist (Altrenogest).
Guthrie HD; Bolt DJ
Biol Reprod; 1985 Oct; 33(3):679-89. PubMed ID: 3931712
[TBL] [Abstract][Full Text] [Related]
16. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
17. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
Jeppsson S; Rannevik G; Thorell JI
Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ovulation by a new low-dose monophasic contraceptive containing gestodene.
Thomas KH; Vankrieken L
Int J Fertil; 1989 Sep; 34 Suppl():10-21. PubMed ID: 2576249
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-ovarian suppression by the standard and half-doses of D-Trp-6-luteinizing hormone-releasing hormone depot.
Balasch J; Gómez F; Casamitjana R; Carmona F; Rivera F; Vanrell JA
Hum Reprod; 1992 Oct; 7(9):1230-4. PubMed ID: 1479003
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic action of high-dose clomiphene in primates pituitary augmentation but with ovarian attenuation.
Marut EL; Hodgen GD
Fertil Steril; 1982 Jul; 38(1):100-4. PubMed ID: 6807720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
